Clinical Practice Guideline, Issues 5-6U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, 1993 |
From inside the book
Results 1-5 of 80
Page 28
... acute and maintenance phase efficacy of non - TCA medications , lithium , or selected anticonvulsants have not been studied in randomized controlled trials ( Schatzberg and Rothschild , 1992 ) . Melancholic Features Guideline : The key ...
... acute and maintenance phase efficacy of non - TCA medications , lithium , or selected anticonvulsants have not been studied in randomized controlled trials ( Schatzberg and Rothschild , 1992 ) . Melancholic Features Guideline : The key ...
Page 128
... Acute Phase Management with Medication and Psychotherapy Objectives and Indications Evidence for Efficacy Selection of a Combined Treatment Frequency of Visits Dosage Adjustments Failure to Respond · · 7. Guideline : Acute Phase ...
... Acute Phase Management with Medication and Psychotherapy Objectives and Indications Evidence for Efficacy Selection of a Combined Treatment Frequency of Visits Dosage Adjustments Failure to Respond · · 7. Guideline : Acute Phase ...
Page 128
... Acute Phase Treatment Objectives of Acute Phase Treatment Indications for Acute Phase Treatment Treatment Selection Selection of Medication Selection of Psychotherapy Alone Selection of Combined Treatment • · Selection of ECT Treatment ...
... Acute Phase Treatment Objectives of Acute Phase Treatment Indications for Acute Phase Treatment Treatment Selection Selection of Medication Selection of Psychotherapy Alone Selection of Combined Treatment • · Selection of ECT Treatment ...
Page 128
... Acute Phase Management with Medication and Psychotherapy Objectives and Indications Evidence for Efficacy Selection of a Combined Treatment Frequency of Visits Dosage Adjustments Failure to Respond · · 7. Guideline : Acute Phase ...
... Acute Phase Management with Medication and Psychotherapy Objectives and Indications Evidence for Efficacy Selection of a Combined Treatment Frequency of Visits Dosage Adjustments Failure to Respond · · 7. Guideline : Acute Phase ...
Page xiv
... acute treatment of major depressive disorder 3. Considerations for acute phase medication 4. Number of randomized controlled trials of medication in patients with major depressive disorder . . 5. Meta - analyses of antidepressant ...
... acute treatment of major depressive disorder 3. Considerations for acute phase medication 4. Number of randomized controlled trials of medication in patients with major depressive disorder . . 5. Meta - analyses of antidepressant ...
Contents
19 | |
20 | |
23 | |
35 | |
43 | |
105 | |
127 | |
147 | |
32 | |
35 | |
41 | |
43 | |
55 | |
67 | |
73 | |
79 | |
85 | |
99 | |
105 | |
119 | |
xiv | |
1 | |
2 | |
7 | |
167 | |
173 | |
1 | |
5 | |
7 | |
14 | |
18 | |
21 | |
34 | |
48 | |
55 | |
57 | |
61 | |
67 | |
77 | |
95 | |
Other editions - View all
Common terms and phrases
acute phase treatment acute treatment affective disorder AHCPR alcoholism amitriptyline antidepressant medications Arch Gen Psychiatry associated bipolar disorder chronic Clin cognitive therapy combined treatment criteria Department of Psychiatry depressed patients Depression Guideline Panel depressive symptoms diabetes diagnosis dosage drug dysthymic disorder efficacy Electroconvulsive therapy episodes of major evaluation family history fluoxetine followup hemoglobin hemoglobinopathy imipramine infants interpersonal psychotherapy Kupfer laboratory major depressive disorder major depressive episode MAOIS marital medical conditions medical disorders Medicine Mental Health meta-analysis mood disorder N/A N/A N/A NIMH nonmood outcome outpatients patients with major percent personality disorder placebo population practitioner prevalence primary care settings psychiatric disorders Psychiatry psychosocial psychotic randomized controlled trials recurrent reported Research samples screening program sickle cell anemia sickle cell disease sickle cell trait side effects somatic specific Strength of Evidence studies suicide syndrome tests trazodone treatment of depression treatment of major tricyclic University weeks Weissman
Popular passages
Page 96 - Endicott J, Spitzer RL: A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia.
Page 44 - JI, Woods G, et al. Prophylaxis with oral penicillin in children with sickle cell anemia.
Page 40 - Presence, while depressed, of two (or more) of the following: ( 1 ) poor appetite or overeating (2) insomnia or hypersomnia (3) low energy or fatigue (4) low self-esteem (5) poor concentration or difficulty making decisions (6) feelings of hopelessness C.
Page 26 - Markedly diminished interest or pleasure in all, or almost all, activities most of the day, nearly every day (as indicated by either subjective account or observation made by others...
Page 128 - Guidelines are systematically developed statements to assist practitioner and patient decisions about appropriate health care for specific clinical conditions.
Page 142 - ... drugs. References: 1. Mendels J, Amin MM, Chouinard G, et al. A comparative study of bupropion and amitriptyline in depressed outpatients. J Clin Psychiatry. 1983;44(5. sec 2):1 18-120.
Page 161 - ... depressive disorders in the medically ill, on endocrine changes in patients with primary depression, and on pharmacokinetic drug interactions. His research has contributed to the understanding of depression in the medically ill, as well as the potential relationship of hypothalamic-pituitary-adrenal axis dysfunction in patients with primary affective disorder. Dr. Kathol has lectured widely, is on the editorial board of several journals, holds membership on the boards of national organizations,...
Page 101 - Paffenbarger RS, McCabe LJ. The effect of obstetric and perinatal events on risk of mental illness in women of childbearing age.
Page 124 - President Association for Clinical Psychosocial Research Don R. Lipsitt, MD President, American Association of General Hospital...
Page 21 - ... inference, available data, and panel consensus. When the evidence is reasonably clear, though modest in amount, these findings are noted, and a tentative recommendation is offered. Thus, the guidelines that follow are coded according to the strength of the available evidence as interpreted by the panel: A Good research-based evidence, with some panel opinion, to support the guideline statement. B Fair research-based evidence, with substantial panel opinion, to support the guideline statement....